Treating neuroleptic malignant syndrome.
D000547:Amantadine / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use*; D003620:Dantrolene / Q000627:therapeutic use*; D005334:Fever / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D009127:Muscle Rigidity / Q000139:chemically induced / Q000188:drug therapy
D014150:Antipsychotic Agents; D001971:Bromocriptine; D000547:Amantadine; D003620:Dantrolene